Clinical or laboratory relevance
Products that address specific needs in diagnosis, treatment and clinical review.
Our portfolio
Current partnerships.
New possibilities.
Our portfolio brings together established programmes and emerging healthcare opportunities, and is designed to evolve as new partnerships grow.
01 · Allergy diagnostics, treatment & digital care
Connected tools across the allergy pathway.
Molecular diagnostics
MADx
Multiplex allergy tests, processing instruments and connected analysis software.
View MADx Diagnosis & immunotherapyDIATER
Specialist allergy diagnosis and molecular immunotherapy solutions.
View DIATER Contact allergyDermagy
A ready-to-use core allergen skin patch test for professional use.
View Dermagy Connected allergy historyAllerLoop
Patient-reported allergy history structured for longitudinal clinical review.
View AllerLoopThis website presents MAG Pharma's current portfolio. Products and partnerships may be added as our work evolves. Availability, intended use, indications where applicable and regulatory status vary by market; please contact us for current information.
How we build the portfolio
Chosen for relevance. Built to evolve.
We add products where local expertise, responsible market development and long-term partnership can create meaningful value.
Specialist engagement
Areas where thoughtful education and close professional relationships support responsible adoption.
Room to grow
A portfolio structure that can welcome new products and partnerships as opportunities develop.